November 19, 2026

Online Shop Review

Online Shop and Product Review

Regeneron (REGN) Withdraws sBLA for Libtayo in Cervical Cancer

1 min read

Regeneron (REGN) Withdraws sBLA for Libtayo in Cervical Cancer

Regeneron (REGN) as well as companion Sanofi willingly take out the supplemental biologics certify application for Libtayo in second-line therapy of innovative cervical cancer.Read More …

Leave a Reply

Your email address will not be published. Required fields are marked *